Detalhe da pesquisa
1.
Serum and Pulmonary Expression Profiles of the Activin Signaling System in Pulmonary Arterial Hypertension.
Circulation;
147(24): 1809-1822, 2023 06 13.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37096577
2.
Characteristics and outcomes of patients developing pulmonary hypertension associated with proteasome inhibitors.
Eur Respir J;
2024 05 02.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38697649
3.
Risk stratification refinements with inclusion of haemodynamic variables at follow-up in patients with pulmonary arterial hypertension.
Eur Respir J;
2024 Apr 25.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38663975
4.
Clinical Phenotype and Outcomes of Pulmonary Hypertension Associated with Myeloproliferative Neoplasms: A Population-based Study.
Am J Respir Crit Care Med;
208(5): 600-612, 2023 09 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37311222
5.
Cytokines as prognostic biomarkers in pulmonary arterial hypertension.
Eur Respir J;
61(3)2023 03.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36549710
6.
COVID-19 in Patients with Pulmonary Hypertension: A National Prospective Cohort Study.
Am J Respir Crit Care Med;
206(5): 573-583, 2022 09 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35549842
7.
An emerging phenotype of pulmonary arterial hypertension patients carrying SOX17 variants.
Eur Respir J;
60(6)2022 12.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35618278
8.
External validation of a refined four-stratum risk assessment score from the French pulmonary hypertension registry.
Eur Respir J;
59(6)2022 06.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34737227
9.
Association between Initial Treatment Strategy and Long-Term Survival in Pulmonary Arterial Hypertension.
Am J Respir Crit Care Med;
204(7): 842-854, 2021 10 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34185620
10.
Phenotype and Outcomes of Pulmonary Hypertension Associated with Neurofibromatosis Type 1.
Am J Respir Crit Care Med;
202(6): 843-852, 2020 09 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32437637
11.
Portopulmonary hypertension in the current era of pulmonary hypertension management.
J Hepatol;
73(1): 130-139, 2020 07.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32145258
12.
Characteristics and outcomes of asthmatic patients with COVID-19 pneumonia who require hospitalisation.
Eur Respir J;
56(5)2020 Nov.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32732333
13.
Prognostic Value of Follow-Up Hemodynamic Variables After Initial Management in Pulmonary Arterial Hypertension.
Circulation;
137(7): 693-704, 2018 02 13.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29070502
14.
French experience of balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension.
Eur Respir J;
53(5)2019 05.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31023842
15.
Haemodynamics and serial risk assessment in systemic sclerosis associated pulmonary arterial hypertension.
Eur Respir J;
52(4)2018 10.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30209196
16.
Sequential multimodal therapy in chronic thromboembolic pulmonary hypertension with mixed anatomical lesions: a proof of concept.
Eur Respir J;
62(5)2023 11.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37802632
17.
Association between Rheumatoid Arthritis and Pulmonary Hypertension: Data from the French Pulmonary Hypertension Registry.
Respiration;
95(4): 244-250, 2018.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29490304
18.
Outcomes of cirrhotic patients with pre-capillary pulmonary hypertension and pulmonary vascular resistance between 2 and 3 Wood Units.
Eur Respir J;
60(2)2022 08.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35680147
19.
Risk assessment, prognosis and guideline implementation in pulmonary arterial hypertension.
Eur Respir J;
50(2)2017 08.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28775050
20.
Prevalence of pulmonary embolism in patients with COVID-19 at the time of hospital admission and role for pre-test probability scores and home treatment.
Eur Respir J;
58(2)2021 08.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33986033